EA200100095A1 - Способ получения кальциевой соли зофеноприла - Google Patents
Способ получения кальциевой соли зофеноприлаInfo
- Publication number
- EA200100095A1 EA200100095A1 EA200100095A EA200100095A EA200100095A1 EA 200100095 A1 EA200100095 A1 EA 200100095A1 EA 200100095 A EA200100095 A EA 200100095A EA 200100095 A EA200100095 A EA 200100095A EA 200100095 A1 EA200100095 A1 EA 200100095A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- zofenopril
- salt
- potassium salt
- calcium salt
- aqueous solution
- Prior art date
Links
- IAIDUHCBNLFXEF-MNEFBYGVSA-N zofenopril Chemical compound C([C@@H](C)C(=O)N1[C@@H](C[C@@H](C1)SC=1C=CC=CC=1)C(O)=O)SC(=O)C1=CC=CC=C1 IAIDUHCBNLFXEF-MNEFBYGVSA-N 0.000 title abstract 5
- 229960002769 zofenopril Drugs 0.000 title abstract 4
- 159000000007 calcium salts Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 230000004048 modification Effects 0.000 abstract 2
- 238000012986 modification Methods 0.000 abstract 2
- XXNAGGDFBCTLQA-DHTOPLTISA-N (2r,4r)-4-phenylsulfanylpyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.C1N[C@@H](C(=O)O)C[C@H]1SC1=CC=CC=C1 XXNAGGDFBCTLQA-DHTOPLTISA-N 0.000 abstract 1
- XYUBQWNJDIAEES-UHFFFAOYSA-N 2-azaniumyl-3-phenylsulfanylpropanoate Chemical compound OC(=O)C(N)CSC1=CC=CC=C1 XYUBQWNJDIAEES-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000010899 nucleation Methods 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Geology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Способ получения полиморфной модификации А кальциевой соли зофеноприла, по существу, в чистой форме, который включает: а) реакцию хлорида S(-)-3-бензоилтио-2-метилпропионовой кислоты с цис-4-фенилтио-L-пролином в воде при pH в интервале от 9,0 до 9,5 и выделение зофеноприла в кислотной форме; б) образование соли из кислого зофеноприла калиевой солью в спиртовом растворе и восстановление полученной калиевой соли; в) превращение калиевой соли в кальциевую соль добавлением водного раствора калиевой соли зофеноприла к водному раствору CaClпри температуре 70-90°C при одновременном затравливании для промотирования осаждения полиморфной модификации А.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI001833A IT1301993B1 (it) | 1998-08-04 | 1998-08-04 | Processo per la preparazione di zofenopril sale di calcio. |
PCT/EP1999/005461 WO2000007984A1 (en) | 1998-08-04 | 1999-07-30 | A process for the preparation of zofenopril calcium salt |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200100095A1 true EA200100095A1 (ru) | 2001-08-27 |
EA003454B1 EA003454B1 (ru) | 2003-06-26 |
Family
ID=11380611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200100095A EA003454B1 (ru) | 1998-08-04 | 1999-07-30 | Способ получения кальциевой соли зофеноприла |
Country Status (32)
Country | Link |
---|---|
US (2) | US6521760B1 (ru) |
EP (1) | EP1102745B1 (ru) |
JP (1) | JP2002522417A (ru) |
KR (1) | KR100593428B1 (ru) |
CN (1) | CN1146538C (ru) |
AT (1) | ATE266635T1 (ru) |
AU (1) | AU5372299A (ru) |
BG (1) | BG65022B1 (ru) |
BR (1) | BR9912842A (ru) |
CA (1) | CA2339283C (ru) |
CU (1) | CU23171A3 (ru) |
CZ (1) | CZ301908B6 (ru) |
DE (1) | DE69917282T2 (ru) |
DK (1) | DK1102745T3 (ru) |
EA (1) | EA003454B1 (ru) |
EE (1) | EE04798B1 (ru) |
ES (1) | ES2221417T3 (ru) |
HK (1) | HK1039616B (ru) |
HR (1) | HRP20010083B1 (ru) |
HU (1) | HU227557B1 (ru) |
IL (1) | IL141222A0 (ru) |
IT (1) | IT1301993B1 (ru) |
NO (1) | NO319773B1 (ru) |
PL (1) | PL193828B1 (ru) |
PT (1) | PT1102745E (ru) |
RS (1) | RS49768B (ru) |
SI (1) | SI1102745T1 (ru) |
SK (1) | SK285527B6 (ru) |
TR (1) | TR200100272T2 (ru) |
UA (1) | UA65628C2 (ru) |
WO (1) | WO2000007984A1 (ru) |
ZA (1) | ZA200100907B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1899297E (pt) * | 2005-07-01 | 2016-03-21 | Generics Uk Ltd | Zofenopril de cálcio em forma polimórfica c |
EA012845B1 (ru) * | 2005-12-09 | 2009-12-30 | Менарини Интернэшнл Оперейшнс Люксембург С. А. | Фармацевтическая композиция, содержащая зофеноприл и hctz, для лечения гипертензии |
DK2041083T3 (en) * | 2006-05-26 | 2015-01-26 | Generics Uk Ltd | Methods for the preparation of zofenopril calcium |
GB0715626D0 (en) * | 2007-08-10 | 2007-09-19 | Generics Uk Ltd | Crystalline form of zofenopril calcium |
US8853421B2 (en) | 2008-02-27 | 2014-10-07 | Generics [Uk] Limited | Crystalline forms of zofenopril calcium |
US20110118328A1 (en) * | 2008-02-27 | 2011-05-19 | Vinayak Gore | Novel crystalline forms |
WO2010084515A2 (en) * | 2009-01-23 | 2010-07-29 | Glenmark Generics Limited | A process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof |
SI23949A (sl) | 2011-12-19 | 2013-06-28 | Silverstone Pharma | Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji |
CN104138359B (zh) * | 2013-05-06 | 2016-03-02 | 扬子江药业集团上海海尼药业有限公司 | 佐芬普利钙片的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
US4154935A (en) * | 1978-02-21 | 1979-05-15 | E. R. Squibb & Sons, Inc. | Halogen substituted mercaptoacylamino acids |
US4316906A (en) | 1978-08-11 | 1982-02-23 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of substituted prolines |
-
1998
- 1998-08-04 IT IT1998MI001833A patent/IT1301993B1/it active IP Right Grant
-
1999
- 1999-07-30 US US09/762,054 patent/US6521760B1/en not_active Expired - Fee Related
- 1999-07-30 WO PCT/EP1999/005461 patent/WO2000007984A1/en active IP Right Grant
- 1999-07-30 IL IL14122299A patent/IL141222A0/xx not_active IP Right Cessation
- 1999-07-30 BR BR9912842-0A patent/BR9912842A/pt not_active Application Discontinuation
- 1999-07-30 JP JP2000563619A patent/JP2002522417A/ja active Pending
- 1999-07-30 SK SK163-2001A patent/SK285527B6/sk not_active IP Right Cessation
- 1999-07-30 AT AT99939416T patent/ATE266635T1/de active
- 1999-07-30 CA CA002339283A patent/CA2339283C/en not_active Expired - Lifetime
- 1999-07-30 PL PL99345814A patent/PL193828B1/pl unknown
- 1999-07-30 EA EA200100095A patent/EA003454B1/ru not_active IP Right Cessation
- 1999-07-30 UA UA2001010590A patent/UA65628C2/ru unknown
- 1999-07-30 PT PT99939416T patent/PT1102745E/pt unknown
- 1999-07-30 HU HU0103826A patent/HU227557B1/hu unknown
- 1999-07-30 EP EP99939416A patent/EP1102745B1/en not_active Expired - Lifetime
- 1999-07-30 AU AU53722/99A patent/AU5372299A/en not_active Abandoned
- 1999-07-30 TR TR2001/00272T patent/TR200100272T2/xx unknown
- 1999-07-30 CN CNB998105171A patent/CN1146538C/zh not_active Expired - Lifetime
- 1999-07-30 DK DK99939416T patent/DK1102745T3/da active
- 1999-07-30 ES ES99939416T patent/ES2221417T3/es not_active Expired - Lifetime
- 1999-07-30 CZ CZ20010408A patent/CZ301908B6/cs not_active IP Right Cessation
- 1999-07-30 KR KR1020017001379A patent/KR100593428B1/ko not_active IP Right Cessation
- 1999-07-30 SI SI9930575T patent/SI1102745T1/xx unknown
- 1999-07-30 DE DE69917282T patent/DE69917282T2/de not_active Expired - Lifetime
- 1999-07-30 EE EEP200100065A patent/EE04798B1/xx unknown
- 1999-07-30 RS YUP-75/01A patent/RS49768B/sr unknown
-
2001
- 2001-01-24 BG BG105176A patent/BG65022B1/bg unknown
- 2001-02-01 ZA ZA200100907A patent/ZA200100907B/en unknown
- 2001-02-01 NO NO20010552A patent/NO319773B1/no not_active IP Right Cessation
- 2001-02-01 HR HR20010083A patent/HRP20010083B1/xx not_active IP Right Cessation
- 2001-02-01 CU CU20010032A patent/CU23171A3/es unknown
-
2002
- 2002-02-21 HK HK02101248.6A patent/HK1039616B/zh not_active IP Right Cessation
- 2002-05-28 US US10/155,129 patent/US6515012B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2007144868A (ru) | Способ получения трищелочных солей метилглицин-n, n-диуксусной кислоты с незначительным содержанием побочных продуктов | |
EA200500318A1 (ru) | Антипирен и способ его получения | |
EA200100095A1 (ru) | Способ получения кальциевой соли зофеноприла | |
CY1108593T1 (el) | Συμπυκνωμενο υδατικο διαλυμα αμβροξολης | |
ATE284866T1 (de) | Verfahren zur herstellung von wässrigen natriummethioninat-lösungen und verwendung dieser lösungen zur herstellung eines granulats | |
ATE422370T1 (de) | Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe | |
ES2192000T3 (es) | Procedimiento para la obtencion de sales de esteres del acido ascorbil-2-fosforico. | |
EA200501734A1 (ru) | Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных | |
EA200401090A1 (ru) | Композиция на основе диклофенака для местного лечения заболеваний орофарингеальной полости | |
EA200100340A1 (ru) | Способ приготовления солей щелочных металлов | |
EA200400739A1 (ru) | Способ получения производных [1,4,5]оксадиазепина | |
ES2149354T3 (es) | Solucion acuosa, estable de folinato. | |
NO20025422D0 (no) | FremgangsmÕte til rensing av et klavulansyresalt | |
TR200101072T2 (tr) | Hayvan gıda katkılarının hazırlanması için işlem | |
EA200200783A2 (ru) | Почвоулучшитель и средство для витализации воды | |
RU2004100978A (ru) | Гербицидный состав и способ его получения | |
RU96122110A (ru) | Способ деструкции адамсита | |
KR960004365A (ko) | 5'-리보뉴클레오티드칼슘의 제조방법 | |
KR850001770A (ko) | N-벤질옥시카르보닐-l-아스파르트산의 큰 결정을 제조하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG MD TJ TM |
|
PC4A | Registration of transfer of a eurasian patent by assignment | ||
MK4A | Patent expired |
Designated state(s): BY KZ RU |